Paired-Ring Mitral Annuloplasty Ring Sizing Device

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEndeavor Health

About this trial

The purpose of this study is to evaluate a novel paired-ring mitral annuloplasty sizing system in humans.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients scheduled for mitral repair surgery

Age 18 years or older

Disqualifiers

Adults unable to consent,

Pregnant women and prisoners.

Emergency operations and those patients in whom mitral repair is not performed in a meaningful way, requiring mitral replacement instead, will be excluded.

Presence of acute endocarditis infection during the initial screening process

Trial population

Patients undergoing mitral valve repair.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Annuloplasy ring sizing device

    Device

    A single time use of a novel sizing tool for mitral valve repair surgery (used ONLY in an observational capacity - this device does NOT influence decision-making during the conduct of the operation in any way).

Treatment groups

22 Participants
are divided into 1 treatment group
Group A: Annuloplasty ring sizing tool1 intervention

Trial outcomes

Primary outcomes

1

Mitral leaflet coaptation length.

Direct measurement of mitral leaflet coaptation length performed with the sizer in position, performed in mm using surgical (disposable) ruler.

Time frame
During surgery, immediately prior to prosthesis implantation.
2

Post-procedure, echocardiography measurements - mitral coaptation length.

Indirect measurement of mitral leaflet coaptation length (mm), using standard intraoperative trans-esophageal echocardiography (TEE) images (measurements performed postoperatively based on archived images).

Time frame
After separation from cardiopulmonary bypass.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.